Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Cuzzubbo

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2021
Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)Thomas Cluzeau, Marie Sebert, Ramy Rahmé, et al.
JCO Precision Oncology|June 1, 2023
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With GliomaPatrick R Benusiglio, Fikret Elder, Mehdi Touat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaSalah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
The New England Journal of Medicine|June 11, 2015
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas, Daniel J Brat, Roel G W Verhaak, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2021
Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)Thomas Cluzeau, Marie Sebert, Ramy Rahmé, et al.
JCO Precision Oncology|June 1, 2023
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With GliomaPatrick R Benusiglio, Fikret Elder, Mehdi Touat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaSalah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
The New England Journal of Medicine|June 11, 2015
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas, Daniel J Brat, Roel G W Verhaak, et al.
Pageof 3